SEO for pharmaceutical and life sciences companies. Keep the audience and approved version explicit.
A life-sciences website may serve patients, professionals and research participants through different information routes. The proposed scope identifies the audience and source status before changing page copy. It gives the medical, legal and regulatory owners a dependency map so approved material is not casually reused in a different market or context.
- “side effects of [drug name]”
- “clinical trials for psoriasis near me”
- “how does [drug] work?”
- “[drug] vs [drug] for migraine”
What holds pharmaceutical and life sciences companies back
Inspect content whose intended audience or approval version is unclear before treating it as an acquisition opportunity.
- Health portals outrank product sites
- Every change needs medical, legal and regulatory review
- Two audiences: patients and professionals
- AI answers summarise from third-party sources
The page types we build first
Condition information, product facts and research participation need distinct boundaries and review routes.
- Condition pagesPlain explanations, medically reviewed.
- Product pagesApproved information, per market.
- HCP pagesBehind the right gate, where required.
- Clinical trial pagesStatus, criteria and locations.
Life-sciences audience-version register
The audience-version register makes reuse and translation dependencies visible. The example is a proposed working record, not evidence of a completed client engagement.
| Situation to check | Proposed scope | Boundary |
|---|---|---|
| A source document is revised | Identify the pages, summaries and translations that depend on it and assign the required review steps. | An updated page date does not establish completed medical or regulatory approval. |
| A page addresses professionals | Confirm the intended audience and any access arrangements through the responsible client team. | A professional label alone does not resolve market-specific publication requirements. |
| A trial description changes status | Use the authorised study record and owner-approved next step for the relevant location. | A public study description does not establish an available place or eligibility. |
| A translation is commissioned | Link it to the approved source version and the reviewer responsible for the target market. | Linguistic completion does not prove approval of the scientific or regulatory meaning. |
Life-sciences audience-version register
ILLUSTRATIVE specification. Client facts and commercial terms require confirmation.
- Material
- [DEFINED PAGE OR DOCUMENT]
- Audience
- [PATIENT / PROFESSIONAL / RESEARCH]
- Market
- [APPLICABLE TERRITORY]
- Approved source
- [VERSION]
- Review chain
- [MEDICAL / LEGAL / REGULATORY]
- Dependent versions
- [TRANSLATION LIST]
What the first handover should make clear
- Deliver a content map that distinguishes audience routes before editorial expansion.
- Record source dependencies for all proposed summaries and translations.
- Keep study-status updates separate from product-promotion copy decisions.
- Agree how approval status and withdrawn material are communicated to publishing teams.
What search and AI answers draw on
Approved source material and the client’s designated reviewers determine the publishable wording.
Typical sources
- Health portals and medical references
- Regulator and trial registries
- Medical journals and news
- Patient communities
- Your condition, product and trial pages
Rules we work within
[CONFIRM: medical, legal and regulatory owners; intended audience; approved source versions.]No invented experts, reviews or statistics. Facts about your product, prices and people are checked by whoever owns them.A summary, not legal advice. Your compliance or legal team has the final say.Where we usually start
The services that fit this industry best. Scope and price in writing before work starts.
Questions from pharmaceutical and life sciences companies
01Can you show relevant pharma & life sciences experience?
[CONFIRM: relevant engagements, permissioned evidence and the person responsible for this scope.]
02Can patient and professional pages reuse the same text?
Only where the responsible reviewers approve the audience and market context. Similar subject matter does not make the two purposes interchangeable.
03Should every source update trigger a translation?
The client should identify affected material and the review decision. Record unaffected versions explicitly rather than assuming all are current.
04Can the agency simplify approved wording?
Proposed edits need the same relevant review before publication. Simplification is not authority to change meaning.
Get a snapshot for your site
- 1Send your site — five issues and where we would start
- 2We check search and AI visibility
- 3PDF by email: five website problems and AI visibility, within two business days of receiving your website URL
We couldn’t send this. Please try again or email hello@topclick.expert.